182 related articles for article (PubMed ID: 23579488)
1. SULT2B1b sulfotransferase: induction by vitamin D receptor and reduced expression in prostate cancer.
Seo YK; Mirkheshti N; Song CS; Kim S; Dodds S; Ahn SC; Christy B; Mendez-Meza R; Ittmann MM; Abboud-Werner S; Chatterjee B
Mol Endocrinol; 2013 Jun; 27(6):925-39. PubMed ID: 23579488
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory Interplay of SULT2B1b Sulfotransferase with AKR1C3 Aldo-keto Reductase in Prostate Cancer.
Park S; Song CS; Lin CL; Jiang S; Osmulski PA; Wang CM; Marck BT; Matsumoto AM; Morrissey C; Gaczynska ME; Chen Y; Mostaghel EA; Chatterjee B
Endocrinology; 2020 Feb; 161(2):. PubMed ID: 31894239
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of SULT2B1b expression alters effects of 3beta-hydroxysteroids on cell proliferation and steroid hormone receptor expression in human LNCaP prostate cancer cells.
He D; Falany CN
Prostate; 2007 Sep; 67(12):1318-29. PubMed ID: 17626250
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of hydroxysteroid sulfotransferase 2B1b promotes hepatic oval cell proliferation by modulating oxysterol-induced LXR activation in a mouse model of liver injury.
Wang Z; Yang X; Chen L; Zhi X; Lu H; Ning Y; Yeong J; Chen S; Yin L; Wang X; Li X
Arch Toxicol; 2017 Jan; 91(1):271-287. PubMed ID: 27052460
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D in Prostate Cancer.
Ahn J; Park S; Zuniga B; Bera A; Song CS; Chatterjee B
Vitam Horm; 2016; 100():321-55. PubMed ID: 26827958
[TBL] [Abstract][Full Text] [Related]
6. SULT2B1: unique properties and characteristics of a hydroxysteroid sulfotransferase family.
Falany CN; Rohn-Glowacki KJ
Drug Metab Rev; 2013 Nov; 45(4):388-400. PubMed ID: 24020383
[TBL] [Abstract][Full Text] [Related]
7. Dehydroepiandrosterone sulfotransferase is a target for transcriptional induction by the vitamin D receptor.
Echchgadda I; Song CS; Roy AK; Chatterjee B
Mol Pharmacol; 2004 Mar; 65(3):720-9. PubMed ID: 14978251
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D receptor agonist EB1089 is a potent regulator of prostatic "intracrine" metabolism.
Doherty D; Dvorkin SA; Rodriguez EP; Thompson PD
Prostate; 2014 Feb; 74(3):273-85. PubMed ID: 24242708
[TBL] [Abstract][Full Text] [Related]
9. Cholesterol Sulfonation Enzyme, SULT2B1b, Modulates AR and Cell Growth Properties in Prostate Cancer.
Vickman RE; Crist SA; Kerian K; Eberlin L; Cooks RG; Burcham GN; Buhman KK; Hu CD; Mesecar AD; Cheng L; Ratliff TL
Mol Cancer Res; 2016 Sep; 14(9):776-86. PubMed ID: 27341831
[TBL] [Abstract][Full Text] [Related]
10. TGFβ1 alters androgenic metabolites and hydroxysteroid dehydrogenase enzyme expression in human prostate reactive stromal primary cells: Is steroid metabolism altered by prostate reactive stromal microenvironment?
Piao YS; Wiesenfeld P; Sprando R; Arnold JT
J Steroid Biochem Mol Biol; 2013 Nov; 138():206-13. PubMed ID: 23770322
[TBL] [Abstract][Full Text] [Related]
11. Expression and characterization of the human 3 beta-hydroxysteroid sulfotransferases (SULT2B1a and SULT2B1b).
Meloche CA; Falany CN
J Steroid Biochem Mol Biol; 2001 Jun; 77(4-5):261-9. PubMed ID: 11457664
[TBL] [Abstract][Full Text] [Related]
12. Human hydroxysteroid sulfotransferase SULT2B1: two enzymes encoded by a single chromosome 19 gene.
Her C; Wood TC; Eichler EE; Mohrenweiser HW; Ramagli LS; Siciliano MJ; Weinshilboum RM
Genomics; 1998 Nov; 53(3):284-95. PubMed ID: 9799594
[TBL] [Abstract][Full Text] [Related]
13. Elevated AKR1C3 expression promotes prostate cancer cell survival and prostate cell-mediated endothelial cell tube formation: implications for prostate cancer progression.
Dozmorov MG; Azzarello JT; Wren JD; Fung KM; Yang Q; Davis JS; Hurst RE; Culkin DJ; Penning TM; Lin HK
BMC Cancer; 2010 Dec; 10():672. PubMed ID: 21134280
[TBL] [Abstract][Full Text] [Related]
14. Characterization of proline-serine-rich carboxyl terminus in human sulfotransferase 2B1b: immunogenicity, subcellular localization, kinetic properties, and phosphorylation.
He D; Falany CN
Drug Metab Dispos; 2006 Oct; 34(10):1749-55. PubMed ID: 16855051
[TBL] [Abstract][Full Text] [Related]
15. Different subcellular localization of sulphotransferase 2B1b in human placenta and prostate.
He D; Meloche CA; Dumas NA; Frost AR; Falany CN
Biochem J; 2004 May; 379(Pt 3):533-40. PubMed ID: 14741047
[TBL] [Abstract][Full Text] [Related]
16. Biochemical characterization and tissue distribution of human SULT2B1.
Geese WJ; Raftogianis RB
Biochem Biophys Res Commun; 2001 Oct; 288(1):280-9. PubMed ID: 11594786
[TBL] [Abstract][Full Text] [Related]
17. Identification and immunohistochemical localization of Sulfotransferase 2B1b (SULT2B1b) in human lung.
He D; Frost AR; Falany CN
Biochim Biophys Acta; 2005 Jun; 1724(1-2):119-26. PubMed ID: 15878639
[TBL] [Abstract][Full Text] [Related]
18. 11β-hydroxyandrostenedione, the product of androstenedione metabolism in the adrenal, is metabolized in LNCaP cells by 5α-reductase yielding 11β-hydroxy-5α-androstanedione.
Swart AC; Schloms L; Storbeck KH; Bloem LM; Toit Td; Quanson JL; Rainey WE; Swart P
J Steroid Biochem Mol Biol; 2013 Nov; 138():132-42. PubMed ID: 23685396
[TBL] [Abstract][Full Text] [Related]
19. An essential role of the CAAT/enhancer binding protein-alpha in the vitamin D-induced expression of the human steroid/bile acid-sulfotransferase (SULT2A1).
Song CS; Echchgadda I; Seo YK; Oh T; Kim S; Kim SA; Cho S; Shi L; Chatterjee B
Mol Endocrinol; 2006 Apr; 20(4):795-808. PubMed ID: 16357103
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a monoclonal antibody for human aldo-keto reductase AKR1C3 (type 2 3alpha-hydroxysteroid dehydrogenase/type 5 17beta-hydroxysteroid dehydrogenase); immunohistochemical detection in breast and prostate.
Lin HK; Steckelbroeck S; Fung KM; Jones AN; Penning TM
Steroids; 2004 Dec; 69(13-14):795-801. PubMed ID: 15582534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
